CPTX
Live / Applied — Extension of time to oppose received (as of 04 Feb 2026)
What this means for you
Not registered yet, but its 23 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98714397
- Mark type
- Stylized text
- Filed
- 23 Aug 2024
- Published for opposition
- 06 Jan 2026
- Attorney of record
- Catherine Parrish Lake
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, DNA, synthetic DNA and single-strand DNA for use in the fields of gene therapy, gene editing, cell therapy, cancer therapy, virus production, DNA-vaccination, gene transfer, immunotherapy, and antivirals; Drug delivery agents in the form of synthetic DNA nanostructures that facilitate the delivery of pharmaceutical preparations and therapeutic agents; Medicines comprised of DNA for gene therapy, gene editing, cell therapy, cancer therapy, virus production, DNA-vaccination, gene transfer, immunotherapy, and antivirals; Medicine delivery agents in the form of synthetic DNA nanostructures that facilitate the delivery of pharmaceutical preparations and therapeutic agents; Diagnostic preparations comprising nucleotide sequences for medical and veterinary purposes.
- Class 042 — Scientific and technological services: Scientific and technological services, namely scientific research and analysis in the field of DNA; biochemical and biotechnological services, namely research and development of custom-specific DNA; research services in the field of DNA, namely, analysis for scientific research purposes and repair technology, mutation and sequencing; biochemical and biotechnological services, namely protein design and development; testing of new products for third parties; scientific DNA screening for scientific research purposes for third parties; protein screening for scientific research purposes for third parties; industrial DNA screening to ensure biopharmaceutical purity and to detect and identify pathogens for third parties for the purposes of scientific and biotechnological research and development; industrial protein screening to ensure biopharmaceutical purity and to detect and identify pathogens for third parties for the purposes of scientific and biotechnological research and development
- Class 044 — Medical, beauty and agricultural services: Medical and pharmaceutical services in the field of DNA, namely, medical analysis of DNA for the diagnosis and treatment of persons, DNA screening for medical purposes, genetic testing for medical purposes
Owner
Prosecution history
- 04 Feb 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 06 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jan 2026 — PUBLISHED FOR OPPOSITION
- 31 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 09 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 09 Oct 2025 — FINAL REFUSAL E-MAILED
- 09 Oct 2025 — FINAL REFUSAL WRITTEN
- 11 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED